Atra stock forecast.

View Atara Biotherapeutics, Inc ATRA investment & stock information. Get the latest Atara Biotherapeutics, Inc ATRA detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.Find real-time BLRX - BioLine RX Ltd stock quotes, company profile, news and forecasts from CNN Business.Tilray Stock Forecast 12-10-2023. Forecast target price for 12-10-2023: $ 1.86. Negative dynamics for Tilray shares will prevail with possible volatility of 11.482%. Pessimistic target level: 1.72. Optimistic target level: 1.94.Nov 24, 2023 · Atara Biotherapeutics Stock Forecast 11-30-2023. Forecast target price for 11-30-2023: $ 0.57. Negative dynamics for Atara Biotherapeutics shares will prevail with possible volatility of 3.481%. Pessimistic target level: 0.56. Optimistic target level: 0.58. CYBN Stock 12 Months Forecast. $5.50. (1067.48% Upside) Based on 4 Wall Street analysts offering 12 month price targets for Cybin in the last 3 months. The average price target is $5.50 with a high forecast of $10.00 and a low forecast of $3.00. The average price target represents a 1067.48% change from the last price of $0.47.

TMC the metals company Inc. (TMC) Stock Forecast & Price Target

22 nov 2023 ... Benchmark actually lowered its SEEL stock forecast price to $1 and has a Speculative Buy rating. ... Tags ATRA, ATRA stock, how to find penny ...The latest Atara Biotherapeutics stock prices, stock quotes, news, and ATRA history to help you invest and trade smarter. ... The 18 analysts offering price forecasts for Atara Biotherapeutics ...

Predicting the weather has long been one of life’s great mysteries — at least for regular folks. Over the years, you’ve probably encountered a few older adults — maybe even your own grandparents — who made some weather predictions based on ...Price target. 16.19 0.00 0.00%. The 7 analysts offering 1 year price forecasts for ATRA have a max estimate of — and a min estimate of —. $0.65. DRRX 5.13%. Outlook Therapeutics Inc. $0.47. OTLK 1.50%. Gamida Cell Ltd. $0.33. GMDA 6.45%. Atara Biotherapeutics Inc. $0.65. ATRA 1.85%. Aclaris ...4 ago 2022 ... " Stock price fell from $12.85 per share to $10.21 per share the next trading day, as the market reacted negatively to this prediction. On ...

Stock Price Forecast. The 2 analysts offering 12-month price forecasts for BioLine RX Ltd have a median target of 14.30, with a high estimate of 21.00 and a low estimate of 7.60. The median ...

Stock Price Forecast. The 7 analysts offering 12-month price forecasts for Arcutis Biotherapeutics Inc have a median target of 10.00, with a high estimate of ...

Oct 24, 2023 · Atara Biotherapeutics Stock Forecast 02 Nov. Presumably, on 11/02/2023, the price of shares will be in the range of $1.24 - $1.28. A $0.04 range width can provide 3.46% volatility. The weighted average price of this range is at $1.26, which is $0.01 lower than the previous day's weighted average price. The Atara Biotherapeutics stock forecast for tomorrow is $ 0.237094, which would represent a -1.21% loss compared to the current price. In the next week, the price of ATRA is expected to increase by 2.28% and hit $ 0.245483. As far as the long-term Atara Biotherapeutics stock forecast is ...Stocks trading online may seem like a great way to make money, but if you want to walk away with a profit rather than a big loss, you’ll want to take your time and learn the ins and outs of online investing first. This guide should help get...Unraveling Atara Biotherapeutics (ATRA) Stock Predictions for 2022 In the dynamic world of stock trading, precise and comprehensive forecasts are crucial. For investors eyeing Atara Biotherapeutics and its promising trajectory, we have meticulously collated insights from various analyst forecasts.Stock Price Forecast. The 2 analysts offering 12-month price forecasts for BioLine RX Ltd have a median target of 14.30, with a high estimate of 21.00 and a low estimate of 7.60. The median ...

3 analysts have issued twelve-month target prices for SoundHound AI's stock. Their SOUN share price targets range from $3.60 to $5.00. On average, they expect the company's stock price to reach $4.53 in the next twelve months. This suggests a possible upside of 96.7% from the stock's current price.Stock Price Forecast. According to 43 stock analysts, the average 12-month stock price forecast for Meta Platforms stock is $345.98, which predicts an increase of 6.51%. The lowest target is $200 and the highest is $435. On average, analysts rate Meta Platforms stock as a strong buy.ASTS Earnings Forecast. Next quarter’s earnings estimate for ASTS is -$0.21 with a range of -$0.21 to -$0.21. The previous quarter’s EPS was -$0.24. ASTS beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 61.91% of the time in the same period.ATRA Signals & Forecast. A buy signal was issued from a pivot bottom point on Friday, November 10, 2023, and so far it has risen 183.59%. Further rise is …

4 ago 2022 ... " Stock price fell from $12.85 per share to $10.21 per share the next trading day, as the market reacted negatively to this prediction. On ...The Atara Biotherapeutics stock forecast for tomorrow is $ 0.237094, which would represent a -1.21% loss compared to the current price. In the next week, the price of ATRA is expected to increase by 2.28% and hit $ 0.245483. As far as the long-term Atara Biotherapeutics stock forecast is ...

Oncology Pharma's stock was trading at $0.3386 at the beginning of the year. Since then, ONPH shares have decreased by 99.9% and is now trading at $0.0002. View the best growth stocks for 2023 here.Oct 26, 2023 · Atara Biotherapeutics Stock Forecast 10 Nov. Presumably, on 11/10/2023, the price of shares will be in the range of $1.31 - $1.36. A $0.05 range width can provide 3.98% volatility. The weighted average price of this range is at $1.34, which is $0.00 lower than the previous day's weighted average price. The Artificial Intelligence stock price gained 35.71% on the last trading day (Tuesday, 28th Nov 2023), rising from $0.0021 to $0.0029. During the last trading day the stock fluctuated 42.86% from a day low at $0.0021 to a day high of $0.0030. The price has fallen in 7 of the last 10 days but is still up by 14% over the past 2 weeks.GDX Signals & Forecast. Mostly positive signals in the chart today. The VanEck Vectors Gold Miners ETF holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long …TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks.comLVTX Stock 12 Months Forecast. $6.00. (354.55% Upside) Based on 3 Wall Street analysts offering 12 month price targets for LAVA Therapeutics in the last 3 months. The average price target is $6.00 with a high forecast of $6.00 and a low forecast of $6.00. The average price target represents a 354.55% change from the last price of $1.32.15 brokers have issued 1-year price targets for Palantir Technologies' stock. Their PLTR share price targets range from $5.00 to $25.00. On average, they anticipate the company's stock price to reach $13.25 in the next year. This suggests that the stock has a possible downside of 34.6%.

S Stock 12 Months Forecast. Based on 20 Wall Street analysts offering 12 month price targets for SentinelOne in the last 3 months. The average price target is $18.97 with a high forecast of $23.00 and a low forecast of $16.50. The average price target represents a 5.86% change from the last price of $17.92.

ASTS Earnings Forecast. Next quarter’s earnings estimate for ASTS is -$0.21 with a range of -$0.21 to -$0.21. The previous quarter’s EPS was -$0.24. ASTS beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 61.91% of the time in the same period.

Stock Price Forecast. The 2 analysts offering 12-month price forecasts for Mustang Bio Inc have a median target of 16.50, with a high estimate of 25.00 and a low estimate of 8.00. The median ...Price target. 16.19 0.00 0.00%. The 7 analysts offering 1 year price forecasts for ATRA have a max estimate of — and a min estimate of —.3 Wall Street analysts have issued 1-year price objectives for Aurora Innovation's stock. Their AUR share price targets range from $1.75 to $7.00. On average, they anticipate the company's share price to reach $3.94 in the next twelve months. This suggests a possible upside of 79.8% from the stock's current price.25 Wall Street analysts have issued 1 year price objectives for Pioneer Natural Resources' stock. Their PXD share price targets range from $236.00 to $332.00. On average, they anticipate the company's share price to reach $258.45 in the next twelve months. This suggests a possible upside of 11.3% from the stock's current price.Find real-time PLTR - Palantir Technologies Inc stock quotes, company profile, news and forecasts from CNN Business.8 brokers have issued 12-month target prices for Cresco Labs' stock. Their CRLBF share price targets range from $2.50 to $34.00. On average, they predict the company's stock price to reach $16.05 in the next twelve months. This suggests a possible upside of 833.1% from the stock's current price. View analysts price targets for CRLBF …The ATRA stock price is -767.69% off its 52-week high price of $5.64 and 69.23% above the 52-week low of $0.20. If we look at the company’s 10-day average daily trading volume, we find that it stood at 5.67 million shares traded. The 3-month trading volume is 3.89 million shares. The consensus among analysts is that Atara Biotherapeutics Inc ...25 abr 2023 ... Atrás. Cuenta de Cloud Iniciar sesión en ... Proper inventory management involves active monitoring of stocks, the use of technology to forecast ...Forecasts are adjusted once a day taking into account the price change of the previous day. To date, analysts have a $14.72 target price for Atara Biotherapeutics stock stock. Today 200 Day Moving Average is the resistance level (3.035 $).ATRA stock had an impressive performance on September 26, 2023, with the potential for significant growth in the coming months. According to CNN Money, seven analysts have provided 12-month price forecasts for Atara Biotherapeutics Inc, with a median target of $20.00.

Unlock tomorrow's (ATRA) stock trends with our detailed analysis. Get insights on Atara Biotherapeutics, Inc.'s performance, backed by data-driven predictions for informed investment.Orchid Island Capital (NYSE:ORC) pays an annual dividend of $1.44 per share and currently has a dividend yield of 19.54%. ORC has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. Read our dividend analysis for ORC.13 brokerages have issued twelve-month price targets for Royal Bank of Canada's stock. Their RY share price targets range from C$122.00 to C$142.00. On average, they predict the company's share price to reach C$133.21 in the next twelve months. This suggests a possible upside of 8.4% from the stock's current price.Instagram:https://instagram. how to find pre market movers1804 liberty silver dollarferrari 275 gtb pricepll stock forecast Planning a trip can be an exciting but challenging task. From booking accommodations to creating an itinerary, there are countless details to consider. One crucial aspect that should never be overlooked is checking the 7-day weather forecas... price of one gold barbest 401k investments for 2023 Oct 24, 2023 · Unraveling Atara Biotherapeutics (ATRA) Stock Predictions for 2021 In the dynamic world of stock trading, precise and comprehensive forecasts are crucial. For investors eyeing Atara Biotherapeutics and its promising trajectory, we have meticulously collated insights from various analyst forecasts. vti stock chart Oct 24, 2023 · Unraveling Atara Biotherapeutics (ATRA) Stock Predictions for 2021 In the dynamic world of stock trading, precise and comprehensive forecasts are crucial. For investors eyeing Atara Biotherapeutics and its promising trajectory, we have meticulously collated insights from various analyst forecasts. Rite Aid Co. (NYSE:RAD) released its quarterly earnings results on Thursday, April, 20th. The company reported ($1.24) earnings per share for the quarter, missing analysts' consensus estimates of ($0.77) by $0.47. The company earned $6.09 billion during the quarter, compared to analyst estimates of $5.70 billion.Forecasts are adjusted once a day taking into account the price change of the previous day. To date, analysts have a $14.72 target price for Atara Biotherapeutics stock stock. Today 200 Day Moving Average is the resistance level (3.035 $).